Abbate I - Search Results

1

Modification of soluble immunological parameters during treatment with interleukin-2.

Abbate I, Correale M, Musci MD, Guida M, Dragone CD, De Santis M, De Lena M. Abbate I, et al. Int J Biol Markers. 1993 Oct-Dec;8(4):227-32. doi: 10.1177/172460089300800405. Int J Biol Markers. 1993. PMID: 8138662

2

Tumor necrosis factor and soluble interleukin-2 receptor: two immunological biomarkers in female neoplasms.

Abbate I, Correale M, Gargano G, Tedone T, Izzi G, Catino A, Musci MD, Dragone D, Cramarossa A. Abbate I, et al. Eur J Gynaecol Oncol. 1992;13(1 Suppl):92-6. Eur J Gynaecol Oncol. 1992. PMID: 1511722

3

Analytical and clinical evaluation of a new tumor marker in breast cancer: CA 27.29.

Correale M, Abbate I, Gargano G, Catino A, Dragone CD, Musci MD, Serio G, Paradiso A, De Lena M. Correale M, et al. Among authors: abbate i. Int J Biol Markers. 1992 Jan-Mar;7(1):43-6. doi: 10.1177/172460089200700106. Int J Biol Markers. 1992. PMID: 1583347

4

Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: biological effects and clinical implications.

Guida M, Abbate I, Casamassima A, Musci MD, Latorre A, Lorusso V, Correale M, De Lena M. Guida M, et al. Among authors: abbate i. Cancer Biother. 1995 Fall;10(3):195-203. doi: 10.1089/cbr.1995.10.195. Cancer Biother. 1995. PMID: 8547958 Clinical Trial.

5

Serum levels of TAG 72 and CA 15.3 in patients with gynaecological neoplasms.

Correale M, Abbate I, Catino A, Tedone T, Musci MD, Dragone D, Gargano G, Izzi G, Cramarossa A. Correale M, et al. Among authors: abbate i. Eur J Gynaecol Oncol. 1992;13(1 Suppl):82-4. Eur J Gynaecol Oncol. 1992. PMID: 1511720

6

[The determination of sialic acid in cancer patients].

Correale M, Abbate I, Gargano G, Catino A, Musci MD, Dragone CD, De Lena M. Correale M, et al. Among authors: abbate i. Minerva Med. 1992 Jul-Aug;83(7-8):427-31. Minerva Med. 1992. PMID: 1522966 Italian.

7

Serum TAG 72 levels in different human carcinomas.

Correale M, Abbate I, Gargano G, Garrubba M, Muncipinto A, Addabbo L, Colangelo D. Correale M, et al. Among authors: abbate i. Int J Rad Appl Instrum B. 1991;18(1):101-3. doi: 10.1016/0883-2897(91)90055-p. Int J Rad Appl Instrum B. 1991. PMID: 2010293

8

The role of tumour markers in ovarian cancer.

Gargano G, Correale M, Abbate I, Falco G, De Frenza N, Lorusso V, De Lena M, De Leonardis A. Gargano G, et al. Among authors: abbate i. Clin Exp Obstet Gynecol. 1990;17(1):23-9. Clin Exp Obstet Gynecol. 1990. PMID: 2194706 Review.

9

Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different nosological entities?

Guida M, Casamassima A, Abbate I, Paradiso A, Zito A, Marzullo F, Lorusso V, Timurian A, Cramarossa A, De Lena M. Guida M, et al. Among authors: abbate i. Tumori. 1994 Oct 31;80(5):370-7. doi: 10.1177/030089169408000512. Tumori. 1994. PMID: 7839469 Review.

10

pS2--a new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer.

Correale M, Abbate I, Paradiso A, Schittulli F, Dragone CD, Tedone T, Gargano G, Catino AM, Musci MD, De Lena M. Correale M, et al. Among authors: abbate i. Cell Biophys. 1993 Jan-Jun;22(1-3):101-10. doi: 10.1007/BF03033869. Cell Biophys. 1993. PMID: 7889536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters